Drug profile · INN
glycomacropeptide formula with docosahexaenoic acid and low phenylalanine
PKU SPHERE20
glycomacropeptide formula with docosahexaenoic acid and low phenylalanine (PKU SPHERE20) is an FDA-listed pharmaceutical active ingredient. Associated with Talion.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — glycomacropeptide formula with docosahexaenoic acid and low phenylalanine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
glycomacropeptide formula with docosahexaenoic acid and low phenylalanine (PKU SPHERE20) is an FDA-listed pharmaceutical active ingredient. Associated with Talion.
Key facts
INN glycomacropeptide formula with docosahexaenoic acid and low phenylalanine
Brand PKU SPHERE20
Originator Talion
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is glycomacropeptide formula with docosahexaenoic acid and low phenylalanine?
glycomacropeptide formula with docosahexaenoic acid and low phenylalanine (PKU SPHERE20) is an FDA-listed pharmaceutical active ingredient. Associated with Talion.
What is the brand name for glycomacropeptide formula with docosahexaenoic acid and low phenylalanine?
PKU SPHERE20 is a marketed brand name for glycomacropeptide formula with docosahexaenoic acid and low phenylalanine. Check FDA Drugs@FDA for the current US label holder and prescribing information.